Cardiac disease in pregnancy risk factors: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}}; '''Associate Editor In Chief:''' {{AC}} | {{CMG}}; '''Associate Editor In Chief:''' {{AC}} | ||
==Overview== | ==Overview== | ||
Women with acquired or congenital heart disease have a higher risk of cardiac complications during pregnancy than the general population. In general, a full evaluation including history, physical examination, echocardiogram, and electrocardiogram should be considered | Women with acquired or [[congenital heart disease]] have a higher risk of cardiac complications during pregnancy than the general population. In general, a full evaluation including history, physical examination, echocardiogram, and electrocardiogram should be considered in the patient maternla patient with underlying heart disease. Further risk stratification and monitoring are dictated by a number of factors, including the presence of prior cardiac events, [[heart failure]], [[valvular heart disease]], and systolic or diastolic dysfunction. | ||
==Cardiac Risk Score in Pregnancy== | ==Cardiac Risk Score in Pregnancy== | ||
Revision as of 17:22, 15 October 2011
|
Cardiac disease in pregnancy Microchapters |
|
Diagnosis |
|---|
|
Catheterization: |
|
Treatment |
|
Special Scenarios:
|
|
Cardiac disease in pregnancy risk factors On the Web |
|
American Roentgen Ray Society Images of Cardiac disease in pregnancy risk factors |
|
Directions to Hospitals Treating Cardiac disease in pregnancy |
|
Risk calculators and risk factors for Cardiac disease in pregnancy risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor In Chief: Anjan K. Chakrabarti, M.D. [2]
Overview
Women with acquired or congenital heart disease have a higher risk of cardiac complications during pregnancy than the general population. In general, a full evaluation including history, physical examination, echocardiogram, and electrocardiogram should be considered in the patient maternla patient with underlying heart disease. Further risk stratification and monitoring are dictated by a number of factors, including the presence of prior cardiac events, heart failure, valvular heart disease, and systolic or diastolic dysfunction.
Cardiac Risk Score in Pregnancy
A prospective study performed by Siu and colleagues identified four predictors of maternal cardiac events.[1] These include:
- A prior cardiac event (e.g., heart failure, transient ischemic attack, or stroke before pregnancy) or arrhythmia
- A baseline New York Heart Association (NYHA) class higher than Class II or cyanosis
- A left-sided heart obstruction (mitral valve area smaller than 2 cm2, aortic valve area less than 1.5 cm2, or peak left ventricular outflow tract gradient more than 30 mm Hg by echocardiography
- Reduced systemic ventricular systolic function (ejection fraction less than 40%)
Based on this study of approximately 600 patients, the estimated risk of a cardiac event in pregnancies with 0, 1, and more than 1 point was 5%, 27%, and 75%, respectively. The authors recommended that those with a low cardiac risk of 0 could safely be delivered in a community hospital, but those at intermediate or high cardiac risk (risk score of 1 or more) should be delivered at a regional center.
High Risk Valvular Lesions
The American College of Cardiology/American Heart Association (ACC/AHA) have developed guidelines that identify the following valvular lesions to be high risk during pregnancy[2]:
- Severe aortic stenosis
- Symptomatic mitral stenosis
- Aortic or mitral regurgitation with NYHA class III to IV symptoms
- Aortic and/or mitral valve disease with left ventricular dysfunction (EF < 40%)
- Aortic and/or mitral valve disease with severe pulmonary hypertension (PA pressure > 75% of systemic pressure)
- Marfan syndrome
- Mechanical prosthetic valve requiring anticoagulation
References
- ↑ Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC; et al. (2001). "Prospective multicenter study of pregnancy outcomes in women with heart disease". Circulation. 104 (5): 515–21. PMID 11479246.
- ↑ Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172.